BBLG
Bone Biologics
BBLG
BBLG
7 hedge funds and large institutions have $55.8K invested in Bone Biologics in 2024 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.
Holders
7
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
UBS Group
Zurich,
Switzerland
| $20.6K | 21,866 | -10,985 | -33% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $14.4K | 15,355 | +15,355 | New |
|
|
HF
3
HRT Financial
New York
| $13K | 14,658 | -7,618 | -34% |
|
4
Citigroup
New York
| $4.65K | 4,948 | +4,948 | New |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $3.18K | 3,387 | +1,601 | +90% |
|
6
Bank of America
Charlotte,
North Carolina
| $19 | 20 | +6 | +43% |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $1 | 1 | +1 | New |
|
8
Morgan Stanley
New York
| – | – | -28,527 | Closed |
|
9
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| – | – | -444 | Closed |
|
|
MWA
10
MFA Wealth Advisors
Pittsburgh,
Pennsylvania
| – | – | -403 | Closed |
|
|
CFGS
11
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|